Visual detection of multidrug resistance gene in living cell using the molecular beacon imaging

A major problem in cancer treatment is the development of resistance to chemotherapeutic agents in tumor cells. Detection of effective prognostic biomarkers and targets are of crucial importance to the management of individualized therapies. However, quantitative analysis of the drug resistance gene had been difficult because of technical limitations. In this study, we designed and used a special hairpin deoxyribonucleic acid (DNA), which served as a beacon for detecting human drug resistance indicater. Upon hybridizing with the target mRNA, the hairpin DNA modified gold nanoparticle beacons (hDAuNP beacons) release the fluorophores attached at 5’end of the oligonucleotide sequence. The fluorescence properties of the beacon before and after the hybridization with the complementary DNA were confirmed in vitro. The hDAuNP beacons could be taken up by living cells with low inherent cytotoxicity and higher stability. hDAuNP beacon imaged by confocal laser scanning microscopy to detect the resistance gene expression. The detected fluorescence in MCF7and MCF7/ADR cells correlates with the specific drug resistance gene expression, which is consistent with the result from Q-PCR. Thus, this approach overcame many of the challenges of previous techniques by creating highly sensitive and effective intracellular probes for monitoring gene expression.

[1]  C. Ahn,et al.  Polymeric nanoparticle-based activatable near-infrared nanosensor for protease determination in vivo. , 2009, Nano letters.

[2]  M. Volm,et al.  P-glycoprotein and glutathione S-transferase pi in childhood acute lymphoblastic leukaemia. , 1994, British Journal of Cancer.

[3]  Pamela A. Silver,et al.  An Alternative Splicing Network Links Cell-Cycle Control to Apoptosis , 2010, Cell.

[4]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[5]  A. Seelig A general pattern for substrate recognition by P-glycoprotein. , 1998, European journal of biochemistry.

[6]  R L Juliano,et al.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.

[7]  Chava Kimchi-Sarfaty,et al.  P-glycoprotein: from genomics to mechanism , 2003, Oncogene.

[8]  Use of molecular beacons to image effects of titanium surface microstructure on beta1 integrin expression in live osteoblast-like cells. , 2010, Biomaterials.

[9]  O. Haas,et al.  MDR1 gene expression and treatment outcome in acute myeloid leukemia. , 1991, Journal of the National Cancer Institute.

[10]  T. Minko,et al.  Nanotechnology approaches for personalized treatment of multidrug resistant cancers. , 2013, Advanced drug delivery reviews.

[11]  J. Bishop The molecular genetics of cancer. , 1987, Science.

[12]  Hongbing Wang,et al.  Differential expression and regulation of brain-derived neurotrophic factor (BDNF) mRNA isoforms in androgen-sensitive motoneurons of the rat lumbar spinal cord , 2010, Molecular and Cellular Endocrinology.

[13]  L. Maquat,et al.  lncRNAs transactivate Staufen1-mediated mRNA decay by duplexing with 3'UTRs via Alu elements , 2010, Nature.

[14]  R. Kim Drugs as P-glycoprotein substrates, inhibitors, and inducers , 2002, Drug metabolism reviews.

[15]  Zhiyu Qian,et al.  Visual detection of STAT5B gene expression in living cell using the hairpin DNA modified gold nanoparticle beacon. , 2013, Biosensors & bioelectronics.

[16]  F. Kwiatkowski,et al.  Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. , 1991, Journal of the National Cancer Institute.

[17]  A. Libchaber,et al.  Single-mismatch detection using gold-quenched fluorescent oligonucleotides , 2001, Nature Biotechnology.

[18]  S. Achilefu,et al.  Highly luminescent water-soluble quaternary Zn-Ag-In-S quantum dots and their unique precursor S/In ratio-dependent spectral shifts , 2014 .

[19]  R. West,et al.  The effect of MDR-1 gene expression on outcome in acute myeloblastic leukaemia. , 1994, British Journal of Cancer.

[20]  R. Singer,et al.  Single mRNAs visualized by ultrastructural in situ hybridization are principally localized at actin filament intersections in fibroblasts , 1994, The Journal of cell biology.

[21]  V. Ling,et al.  P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. , 1991, The New England journal of medicine.

[22]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[23]  Robert Langer,et al.  Self-assembled gold nanoparticle molecular probes for detecting proteolytic activity in vivo. , 2010, ACS nano.

[24]  Lippincott-Schwartz,et al.  Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page , 2022 .

[25]  Sanjay Tyagi,et al.  Molecular Beacons: Probes that Fluoresce upon Hybridization , 1996, Nature Biotechnology.